These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 2288939)

  • 1. Losec (omeprazole/MSD).
    Swartz ML
    Gastroenterol Nurs; 1990; 12(4):274-6. PubMed ID: 2288939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of Zollinger-Ellison syndrome and omeprazole therapy on gastric oxyntic endocrine cells.
    Maton PN; Lack EE; Collen MJ; Cornelius MJ; David E; Gardner JD; Jensen RT
    Gastroenterology; 1990 Oct; 99(4):943-50. PubMed ID: 1697548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Omeprazole in the treatment of Zollinger-Ellison syndrome and histamine H2-antagonist refractory ulcers.
    Meijer JL; Jansen JB; Lamers CB
    Digestion; 1989; 44 Suppl 1():31-9. PubMed ID: 2575060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of omeprazole in Zollinger-Ellison syndrome: a prospective nine-year study of efficacy and safety.
    Metz DC; Strader DB; Orbuch M; Koviack PD; Feigenbaum KM; Jensen RT
    Aliment Pharmacol Ther; 1993 Dec; 7(6):597-610. PubMed ID: 8161665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of long-term therapy with low doses of omeprazole in the control of gastric acid secretion in Zollinger-Ellison syndrome patients.
    Corleto V; Annibale B; D'Ambra G; Saggioro A; Ferrua B; Cassetta MR; Delle Fave G
    Aliment Pharmacol Ther; 1993 Apr; 7(2):167-73. PubMed ID: 8485270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Omeprazole: a new approach to gastric acid suppression.
    Buhl K; Clearfield HR
    Am Fam Physician; 1990 Apr; 41(4):1225-7. PubMed ID: 2321497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Currently used doses of omeprazole in Zollinger-Ellison syndrome are too high.
    Metz DC; Pisegna JR; Fishbeyn VA; Benya RV; Feigenbaum KM; Koviack PD; Jensen RT
    Gastroenterology; 1992 Nov; 103(5):1498-508. PubMed ID: 1426868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term lansoprazole control of gastric acid and pepsin secretion in ZE and non-ZE hypersecretors: a prospective 10-year study.
    Hirschowitz BI; Simmons J; Mohnen J
    Aliment Pharmacol Ther; 2001 Nov; 15(11):1795-806. PubMed ID: 11683694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous omeprazole in patients with Zollinger-Ellison syndrome undergoing surgery.
    Vinayek R; Frucht H; London JF; Miller LS; Stark HA; Norton JA; Cederberg C; Jensen RT; Gardner JD; Maton PN
    Gastroenterology; 1990 Jul; 99(1):10-6. PubMed ID: 1971604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of patients with Zollinger-Ellison syndrome.
    Mignon M; Pospai D; Forestier S; Vatier J; Vallot T
    Clin Ther; 1993; 15 Suppl B():22-31. PubMed ID: 8205592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term efficacy and safety of omeprazole in patients with Zollinger-Ellison syndrome: a prospective study.
    Maton PN; Vinayek R; Frucht H; McArthur KA; Miller LS; Saeed ZA; Gardner JD; Jensen RT
    Gastroenterology; 1989 Oct; 97(4):827-36. PubMed ID: 2777040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Dose-response effect of lansoprazole in patients with Zollinger-Ellison syndrome].
    Mignon M; Hochlaf S; Forestier S; Ruszniewski P; Vatier J; Joubert-Collin M
    Gastroenterol Clin Biol; 1994; 18(1):13-6. PubMed ID: 8187984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Omeprazole. Its pharmacology and therapeutic efficacy].
    Protzer U; Holtermüller KH
    Dtsch Med Wochenschr; 1993 Feb; 118(7):230-9. PubMed ID: 8440164
    [No Abstract]   [Full Text] [Related]  

  • 14. Gastric carcinoid tumours in patients with Zollinger-Ellison syndrome on long-term omeprazole.
    Goldfain D; le Bodic MF; Lavergne A; Galian A; Modigliani R
    Lancet; 1989 Apr; 1(8641):776-7. PubMed ID: 2564577
    [No Abstract]   [Full Text] [Related]  

  • 15. Omeprazole: a comprehensive review.
    Massoomi F; Savage J; Destache CJ
    Pharmacotherapy; 1993; 13(1):46-59. PubMed ID: 8437967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omeprazole.
    Maton PN
    N Engl J Med; 1991 Apr; 324(14):965-75. PubMed ID: 2002819
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of omeprazole in patients with Zollinger-Ellison syndrome.
    Frucht H; Maton PN; Jensen RT
    Dig Dis Sci; 1991 Apr; 36(4):394-404. PubMed ID: 2007355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Indications and use of omeprazole in esophago-gastro-duodenal diseases].
    Martín de Argila C; Boixeda de Miquel D; Moreira Vicente V; García Plaza A
    Rev Clin Esp; 1999 Nov; 199(11):729-39. PubMed ID: 10638238
    [No Abstract]   [Full Text] [Related]  

  • 19. Omeprazole.
    Med Lett Drugs Ther; 1990 Mar; 32(813):19-21. PubMed ID: 2179694
    [No Abstract]   [Full Text] [Related]  

  • 20. [Long-term efficacy and tolerability of omeprazole in 20 patients with severe Zollinger-Ellison syndrome].
    Cadranel JF; Ruszniewski P; Elouaer-Blanc L; Lehy T; Delchier JC; Cadiot G; Florent C; Vatier J; Mignon M
    Gastroenterol Clin Biol; 1989; 13(8-9):654-62. PubMed ID: 2806801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.